Current Clinical Trials on Vitiligo / Switra in Ayurveda / Venpadai in Siddha

Current Clinical Trials on Vitiligo (Switra in Ayurveda, Venpadai in Siddha)

1. HI-Light Pilot Trial for Vitiligo: Hand Held NB-UVB for Early or Focal Vitiligo at Home
2. Online Health Survey of Patients With Vitiligo Vulgaris/ Online Survey of Pediatric Patients With Vitiligo
3. Vitiligo Skin Transplantation
4. Ginkgo Biloba for the Treatment of Vitiligo Vulgaris in Adolescents
5. Vitiligo and the Koebner Phenomenon (Model of Vitiligo Induction and Therapy: a Clinical and Immunological Analysis)
6. Effect of Fluticasone Proprionate 0.05% on Narrow Band UV-B in Active Vitiligo
7. Afamelanotide and Narrow-Band Ultraviolet B (NB-UVB) Light in the Treatment of Nonsegmental Vitiligo (NSV)
8. Clinical Trial of Simvastatin to Treat Generalized Vitiligo
9. Botulinum Toxin Treatment for Localized Vitiligo
10. Afamelanotide and Narrow-Band Ultraviolet B (NB-UVB) Light in the Treatment of Nonsegmental Vitiligo
11. Punchgrafting Techniques for Vitiligo
12. Efficacy and Safety of ACH24 in the Treatment of Vitiligo
13. Treatment of Vitiligo With Low-energy Visible Light Laser
14. Narrowband UVB Treatment in Patients With Vitiligo
15. Topical Bimatoprost Solution 0.03%in Stable Vitiligo
16. Study of Applications of Autologous Epidermal Cells in Liquid Phase in the Treatment of Vitiligo
17. Epidermal Cell Transplantation in Vitiligo Skin With and Without Narrow-band Ultraviolet B (UVB) Treatment
18. Comparison of Efficacy and Safety of 0.1% Tacrolimus and 0.1% Mometasone Furoate for Adult Vitiligo
19. Determining the Tolerance of Depigmented Skin to Targeted Phototherapy Using UVB in Patients With Vitiligo
20. Questionnaire and Laboratory Data on Vitiligo Vulgaris
21. Emervel Deep Lidocaine vs. Juvederm® Ultra Plus in Treatment of Moderate to Severe Facial Wrinkles and Folds
22. Safety Study of Cosmetic Tissue Augmentation in People of Color
23. Trial for the Evaluation of the Effect of Systemic Low-dose Interleukin-2 (IL-2) on the Immunogenicity of a Vaccine Comprising Synthetic Melanoma Peptides Administered With Granulocyte-macrophage Colony-stimulating Factor (GM-CSF)-In-Adjuvant, in Patients With High Risk Melanoma
24. Evaluation of Rosacea-related Inflammatory Biochemical Markers in Adult Skin When Treated With Oracea® vs Placebo
25. A Post-Market Study to Evaluate Adverse Event Incidence Rates in Patients With Skin of Color Undergoing Correction of Nasolabial Folds With Hylaform, Hylaform Plus and Captique.
26. Assessment of Atrophogenic Potential of Triple Combination Cream for Treatment of Melasma
27. Post Market Safety Study and Effectiveness With Evolence in Subjects With Skin Color Types IV-VI